Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
LUCD

LUCD - Lucid Diagnostics Inc. Stock Price, Fair Value and News

$1.03+0.02 (+1.98%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

LUCD Price Action

Last 7 days

-3.7%

Last 30 days

-14.9%

Last 90 days

-25.4%

Trailing 12 Months

7.3%

LUCD RSI Chart

LUCD Valuation

Market Cap

141.6M

Price/Earnings (Trailing)

-2.66

Price/Sales (Trailing)

32.59

EV/EBITDA

-1.8

Price/Free Cashflow

-3.24

LUCD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

LUCD Fundamentals

LUCD Revenue

Revenue (TTM)

4.3M

Rev. Growth (Qtr)

3.18%

LUCD Earnings

Earnings (TTM)

-53.3M

Earnings Growth (Yr)

15.96%

Earnings Growth (Qtr)

-134.22%

LUCD Profitability

Operating Margin

86.72%

EBT Margin

-1226.07%

Return on Equity

-206.25%

Return on Assets

-100.16%

Free Cashflow Yield

-30.88%

LUCD Investor Care

Shares Dilution (1Y)

166.50%

Diluted EPS (TTM)

-0.87

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20254.1M4.3M4.4M0
20243.0M3.8M4.2M4.3M
2023634.0K793.0K1.5M2.4M
2022533.0K481.0K429.0K377.0K
2021000585.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About Lucid Diagnostics Inc.

LUCD
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma (EAC). It offers EsoCheck, a cell collection device to prevent EAC deaths; and EsoGuard, an Esophageal DNA Test. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
0
 CEO
 WEBSITEluciddx.com
 SECTORHealthcare
 INDUSTRYMedical Devices

Lucid Diagnostics Inc. Frequently Asked Questions

What is the ticker symbol for Lucid Diagnostics Inc.? What does LUCD stand for in stocks?

LUCD is the stock ticker symbol of Lucid Diagnostics Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Lucid Diagnostics Inc. (LUCD)?

As of Wed Dec 03 2025, market cap of Lucid Diagnostics Inc. is 141.63 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LUCD stock?

You can check LUCD's fair value in chart for subscribers.

Is Lucid Diagnostics Inc. a good stock to buy?

The fair value guage provides a quick view whether LUCD is over valued or under valued. Whether Lucid Diagnostics Inc. is cheap or expensive depends on the assumptions which impact Lucid Diagnostics Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LUCD.

What is Lucid Diagnostics Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, LUCD's PE ratio (Price to Earnings) is -2.66 and Price to Sales (PS) ratio is 32.59. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LUCD PE ratio will change depending on the future growth rate expectations of investors.